Contraception

In the Clinic2 October 2012ContraceptionElisabeth J. Woodhams, MD, Melissa Gilliam, MD, MPH, Deborah Cotton, MD, MPH, Darren Taichman, MD, PhD, and Sankey Williams, MDElisabeth J. Woodhams, MDSearch for more papers by this author, Melissa Gilliam, MD, MPHSearch for more papers by this author, Deborah Cotton, MD, MPHSearch for more papers by this author, Darren Taichman, MD, PhDSearch for more papers by this author, and Sankey Williams, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-157-7-201210020-01004 SectionsSupplemental MaterialAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Editor's Note: This issue of In the Clinic has been updated.Nearly half of all pregnancies in the United States are unintended, and half of those will end in abortion, resulting in nearly 1.2 million abortions per year in the United States (1). Unintended pregnancy places significant emotional and financial burdens on the women and men involved, including negative effects on their families and children. Half of unintended pregnancies result from a contraceptive failure secondary to incorrect or inconsistent use or method failure; the other half results from nonuse of any method (2). More than 99% of women in the ...References1. Finer LB, Zolna MR. Unintended pregnancy in the United States: incidence and disparities, 2006. Contraception. 2011;84:478-85. [PMID: 22018121] Google Scholar2. Winner B, Peipert JF, Zhao Q, et al. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012;366:1998-2007. [PMID: 22621627] Google Scholar3. Trussell J. Contraceptive efficacy. In: Hatcher RA, Nelson AL, et al, eds. Contraceptive Technology. New York, NY: Ardent Media; 2008 Google Scholar4. Grimes DA, Lopez LM, O'Brien PA, Raymond EG. Progestin-only pills for contraception. Cochrane Database Syst Rev. 2010:CD007541. [PMID: 20091638] Google Scholar5. Cates W. Vaginal barriers and spermicides. In: Hatcher RA, Nelson AL, et al, eds. Contraceptive Technology. New York, NY: Ardent Media; 2008. Google Scholar6. Jamieson DJ, Costello C, Trussell J, et al; US Collaborative Review of Sterilization Working Group. The risk of pregnancy after vasectomy. Obstet Gynecol. 2004;103:848-50. [PMID: 15121555] Google Scholar7. Peterson HB, Xia Z, Hughes JM, Wilcox LS, Tylor LR, Trussell J. The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. Am J Obstet Gynecol. 1996;174:1161-8; discussion 1168-70. [PMID: 8623843] Google Scholar8. Hohmann H, Creinin MD. The contraceptive implant. Clin Obstet Gynecol. 2007;50:907-17. [PMID: 17982333] Google Scholar9. Graesslin O, Korver T. The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience. Eur J Contracept Reprod Health Care. 2008;13 Suppl 1:4-12. [PMID: 18330813] Google Scholar10. Kost K, Singh S, Vaughan B, Trussell J, Bankole A. Estimates of contraceptive failure from the 2002 National Survey of Family Growth. Contraception. 2008;77:10-21. [PMID: 18082661] Google Scholar11. Ahrendt HJ, Nisand I, Bastianelli C, et al. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone. Contraception. 2006;74:451-7. [PMID: 17157101] Google Scholar12. Creinin MD, Meyn LA, Borgatta L, et al. Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial. Obstet Gynecol. 2008;111:267-77. [PMID: 18238962] Google Scholar13. Lopez LM, Grimes DA, Gallo MF, Schulz KF. Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database Syst Rev. 2010:CD003552. [PMID: 20238323] Google Scholar14. Zieman M, Guillebaud J, Weisberg E, Shangold GA, Fisher AC, Creasy GW. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data. Fertil Steril. 2002;77:S13-8. [PMID: 11849631] Google Scholar15. Warner L. Male condoms. In: Hatcher RA, Nelson AL, et al, eds. Contraceptive Technology. New York, NY: Ardent Media; 2008:297-316. Google Scholar16. Rosenberg MJ, Waugh MS. Latex condom breakage and slippage in a controlled clinical trial. Contraception. 1997;56:17-21. [PMID: 9306027] Google Scholar17. Trussell J, Sturgen K, Strickler J, Dominik R1994;26:66-72. [PMID: 8033980] Google Scholar18. Stewart F, Van Look J. Emergency contraception. In: Hatcher RA, Nelson AL, et al, eds. Contraceptive Technology. New York, NY: Ardent Media; 2008. Google Scholar19. Jayakrishnan K, Baheti SN. Laparoscopic tubal sterilization reversal and fertility outcomes. J Hum Reprod Sci. 2011;4:125-9. [PMID: 22346079] Google Scholar20. Harada T, Momoeda M, Terakawa N, Taketani Y, Hoshiai H. Evaluation of a low-dose oral contraceptive pill for primary dysmenorrhea: a placebo-controlled, double-blind, randomized trial. Fertil Steril. 2011;95:1928-31. [PMID: 21420678] Google Scholar21. Milsom I, Lete I, Bjertnaes A, et al. Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone. Hum Reprod. 2006;21:2304-11. [PMID: 16763008] Google Scholar22. Miller L, Notter KM. Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial. Obstet Gynecol. 2001;98:771-8. [PMID: 11704167] Google Scholar23. Stewart FH, Kaunitz AM, Laguardia KD, . Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial. Obstet Gynecol. 2005;105:1389-96. [PMID: 15932834] Google Scholar24. Freeman EW. Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder. Eur J Contracept Reprod Health Care. 2002;7 Suppl 3:27-34. [PMID: 12659404] Google Scholar24a. Lopez LM, Kaptein AA, Helmerhorst FM. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev. 2012;2:CD006586. Google Scholar25. Arowojolu AO, Gallo MF, Lopez LM, Grimes DA. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev. 2012;6:CD004425. [PMID: 22696343] Google Scholar26. Mueck AO, Seeger H, Rabe T. Hormonal contraception and risk of endometrial cancer: a systematic review. Endocr Relat Cancer. 2010;17:R263-71. [PMID: 20870686] Google Scholar27. Crane K. Oral contraceptives as ovarian cancer prevention. J Natl Cancer Inst. 2011;103:1286-8. [PMID: 21852259] Google Scholar28. Cibula D, Gompel A, Mueck AO, et al. Hormonal contraception and risk of cancer. Hum Reprod Update. 2010;16:631-50. [PMID: 20543200] Google Scholar29. Marjoribanks J, Lethaby A, Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev. 2006:CD003855. [PMID: 16625593] Google Scholar30. Funk S, Miller MM, Mishell DR Jr, et al. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception. 2005;71:319-26. [PMID: 15854630] Google Scholar31. Lockhat FB, Emembolu JO, Konje JC. The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intrauterine administered progestogen (levonorgestrel): a 3 year follow-up. Hum Reprod. 2005;20:789-93. [PMID: 15608040] Google Scholar32. Lethaby AE, Cooke I, Rees M. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev. 2005:CD002126. [PMID: 16235297] Google Scholar33. Wildemeersch D, Janssens D, Pylyser K, et al. Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: long-term follow-up. Maturitas. 2007;57:210-3. [PMID: 17270370] Google Scholar34. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet. 1995;346:1582-8. [PMID: 7500749] Google Scholar35. Jick SS, Hagberg KW, Hernandez RK, Kaye JA. Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism. Contraception. 2010;81:16-21. [PMID: 20004268] Google Scholar36. Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet. 1996;348:498-505. [PMID: 8757151] Google Scholar37. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet. 1996;347:1713-27. [PMID: 8656904] Google Scholar38. Marchbanks PA, Curtis KM, Mandel MG, et al. Oral contraceptive formulation and risk of breast cancer. Contraception. 2012;85:342-50. [PMID: 22067757] Google Scholar39. Marchbanks PA, McDonald JA, Wilson HG, et al. Oral contraceptives and the risk of breast cancer. N Engl J Med. 2002;346:2025-32. [PMID: 12087137] Google Scholar40. Gallo MF, Grimes DA, Lopez LM, Schulz KF, d'Arcangues C. Combination injectable contraceptives for contraception. Cochrane Database Syst Rev. 2008:CD004568. [PMID: 18843662] Google Scholar41. Grimes DA, Hubacher D, Lopez LM, Schulz KF. Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use. Cochrane Database Syst Rev. 2006:CD006034. [PMID: 17054271] Google Scholar42. Grimes DA, Schulz KF. Antibiotic prophylaxis for intrauterine contraceptive device insertion. Cochrane Database Syst Rev. 2001:CD001327. [PMID: 11405986] Google Scholar43. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 121: Long-acting reversible contraception: Implants and intrauterine devices. Obstet Gynecol. 2011;118:184-96. [PMID: 21691183] Google Scholar44. The U.S. Medical Eligibility Criteria for Contraceptive Use. MMWR Morb Mortal Wkly Rep. 2010;59(RR04):1-85. Google Scholar45. Trussell J. Choosing a contraceptive: efficacy, safety, and personal considerations. In: Hatcher RA, Nelson AL, et al, eds. Contraceptive Technology. New York, NY: Ardent Media; 2009. Google Scholar46. Barnhart KT, Schreiber CA. Return to fertility following discontinuation of oral contraceptives. Fertil Steril. 2009;91:659-63. [PMID: 19268187] Google Scholar47. Hofmeyr GJ, Singata M, Lawrie TA. Copper containing intrauterine devices versus depot progestogens for contraception. Cochrane Database Syst Rev. 2010:CD007043. [PMID: 20556773] Google Scholar48. Speroff L, Darney PD. The postpartum Period, Breastfeeding, and Contraception. A Clinical Guide for Contraception. Philadelphia, PA: Lippincott Williams & Wilkins; 2011 Google Scholar49. Grimes D, Schulz K, Van Vliet H, Stanwood N. Immediate post-partum insertion of intrauterine devices. Cochrane Database Syst Rev. 2003:CD003036. [PMID: 12535449] Google Scholar50. Trussell J, Lalla AM, Doan QV, Reyes E, Pinto L, Gricar J. Cost effectiveness of contraceptives in the United States. Contraception. 2009;79:5-14. [PMID: 19041435] Google Scholar51. Insurance Coverage of Contraceptives. Guttmacher State Policies in Brief. 2012. www.guttmacher.org/statecenter/spibs/spib_ICC.pdf. Accessed 9 August 2012. Google Scholar52. Eisenberg DL, Stika C, Desai A, Baker D, Yost KJ. Providing contraception for women taking potentially teratogenic medications: a survey of internal medicine physicians' knowledge, attitudes and barriers. J Gen Intern Med. 2010;25:291-7. [PMID: 20087677] Google Scholar53. Lohr PA, Schwarz EB, Gladstein JE, et al. Provision of contraceptive counseling by internal medicine residents. J Womens Health (Larchmt). 2009;18:127-31. [PMID:19072725] Google Scholar54. Lohr PA, Schwarz EB, Gladstein JE, et al. Provision of contraceptive counseling by internal medicine residents. International Family Planning Perspectives. 2001;27:63-70. Google Scholar Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByCombined Oral Contraceptive in Adolescent and Young Adult Women: Current Evidence and Future PerspectivesIs cost a structural barrier preventing men who have sex with men accessing condoms? A systematic reviewContraceptive Counseling by General Internal Medicine Faculty and Residents 2 October 2012Volume 157, Issue 7Page: ITC4-1KeywordsAdolescentsContraceptivesEstrogensFemale contraceptionLigation assayOral contraceptive therapyOvulationPregnancyVasectomy ePublished: 2 October 2012 Issue Published: 2 October 2012 CopyrightCopyright © 2012 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...